|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/198 | |
| A61P 25/28 | |||
| A61P 25/24 | |||
| A61P 25/14 | |||
| A61P 25/04 |
| (11) | Number of the document | 2948140 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14743570.5 |
| Date of filing the European patent application | 2014-01-22 | |
| (97) | Date of publication of the European application | 2015-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/012598 |
| Date | 2014-01-22 |
| (87) | Number | WO 2014/116739 |
| Date | 2014-07-31 |
| (30) | Number | Date | Country code |
| 201361849191 P | 2013-01-22 | US |
| (72) |
SNODGRASS, H., Ralph, US
CATO, Allen, E., US
HICKLIN, Jack, S., US
|
| (73) |
Vistagen Therapeutics, Inc.,
343 Allerton Avenue, South San Francisco, CA 94080,
US
|
| (54) | DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE |
| DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE |